Name:
Adduct:
Polarity:
Z:
m/z:
±:
CCS: Å
±: %
SMI:
Type:

Make a CSV file containing information about your queries.
Then upload the CSV file below and click on "Make Queries" to view the results online
and click "Download Results" to download the entire results in one excel file.
An example of the CSV file can be found below

Download Example CSV


**Make sure the header column names are as follows**

...



Upload a CSV file

1
May, J. C. et al. Conformational Ordering of Biomolecules in the Gas Phase: Nitrogen Collision Cross Sections Measured on a Prototype High Resolution Drift Tube Ion Mobility-Mass Spectrometer. Anal. Chem. 86, 2107–2116 (2014).


2
Paglia, G. et al. Ion Mobility Derived Collision Cross Sections to Support Metabolomics Applications. Anal. Chem. 86, 3985–3993 (2014).


3
Groessl, M., Graf, S. & Knochenmuss, R. High resolution ion mobility-mass spectrometry for separation and identification of isomeric lipids. Analyst 140, 6904–6911 (2015).


4
Zhou, Z., Shen, X., Tu, J. & Zhu, Z.-J. Large-Scale Prediction of Collision Cross-Section Values for Metabolites in Ion Mobility-Mass Spectrometry. Anal. Chem. 88, 11084–11091 (2016).


5
Hines, K. M., Herron, J. & Xu, L. Assessment of altered lipid homeostasis by HILIC-ion mobility-mass spectrometry-based lipidomics. The Journal of Lipid Research 58, 809–819 (2017).


6
Bijlsma, L. et al. Prediction of Collision Cross-Section Values for Small Molecules: Application to Pesticide Residue Analysis. Anal. Chem. 89, 6583–6589 (2017).


7
Hines, K. M., Ross, D. H., Davidson, K. L., Bush, M. F. & Xu, L. Large-Scale Structural Characterization of Drug and Drug-Like Compounds by High-Throughput Ion Mobility-Mass Spectrometry. Anal. Chem. 89, 9023–9030 (2017).


8
Stow, S. M. et al. An Interlaboratory Evaluation of Drift Tube Ion Mobility–Mass Spectrometry Collision Cross Section Measurements. Anal. Chem. 89, 9048–9055 (2017).


9
Zhou, Z., Tu, J., Xiong, X., Shen, X. & Zhu, Z.-J. LipidCCS: Prediction of Collision Cross-Section Values for Lipids with High Precision To Support Ion Mobility–Mass Spectrometry-Based Lipidomics. Anal. Chem. 89, 9559–9566 (2017).


10
Zheng, X. et al. A structural examination and collision cross section database for over 500 metabolites and xenobiotics using drift tube ion mobility spectrometry. Chem. Sci. 8, 7724–7736 (2017).


11
Hines, K. M. et al. Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics. mSphere 2, 99–16 (2017).


12
Lian, R. et al. Ion mobility derived collision cross section as an additional measure to support the rapid analysis of abused drugs and toxic compounds using electrospray ion mobility time-of-flight mass spectrometry. Anal. Methods 10, 749–756 (2018).


13
Mollerup, C. B., Mardal, M., Dalsgaard, P. W., Linnet, K. & Barron, L. P. Prediction of collision cross section and retention time for broad scope screening in gradient reversed-phase liquid chromatography-ion mobility-high resolution accurate mass spectrometry. Journal of Chromatography A 1542, 82–88 (2018).


14
Righetti, L. et al. Ion mobility-derived collision cross section database: Application to mycotoxin analysis. Analytica Chimica Acta 1014, 50–57 (2018).


15
Tejada-Casado, C. et al. Collision cross section (CCS) as a complementary parameter to characterize human and veterinary drugs. Analytica Chimica Acta 1043, 52–63 (2018).


16
Nichols, C. M. et al. Untargeted Molecular Discovery in Primary Metabolism: Collision Cross Section as a Molecular Descriptor in Ion Mobility-Mass Spectrometry. Anal. Chem. 90, 14484–14492 (2018).


17
Hines, K. M. & Xu, L. Lipidomic consequences of phospholipid synthesis defects in Escherichia coli revealed by HILIC-ion mobility-mass spectrometry. Chemistry and Physics of Lipids 219, 15–22 (2019).


18
Leaptrot, K. L., May, J. C., Dodds, J. N. & McLean, J. A. Ion mobility conformational lipid atlas for high confidence lipidomics. Nature Communications 1–9 (2019).


19
Blaženović, I. et al. Increasing Compound Identification Rates in Untargeted Lipidomics Research with Liquid Chromatography Drift Time–Ion Mobility Mass Spectrometry. Anal. Chem. 90, 10758–10764 (2018).


20
Tsugawa, H. et al. MS-DIAL 4: accelerating lipidomics using an MS/MS, CCS, and retention time atlas. bioRxiv 37, 513 (2020).


21
Poland, J. C. et al. Collision Cross Section Conformational Analyses of Bile Acids via Ion Mobility–Mass Spectrometry. Journal of the American Society for Mass Spectrometry 31, 1625–1631 (2020).


22
Dodds, J. et al. Rapid Characterization of Per- and Polyfluoroalkyl Substances (PFAS) by Ion Mobility Spectrometry−Mass Spectrometry (IMS-MS). Anal. Chem. 92, 4427-4435 (2020).


23
Celma, A. et al. Improving Target and Suspect Screening High-Resolution Mass Spectrometry Workflows in Environmental Analysis by Ion Mobility Separation. Environ. Sci. Technol. 54, 15120-15131 (2020)


24
Belova, L. et al. Ion Mobility-High-Resolution Mass Spectrometry (IM-HRMS) for the Analysis of Contaminants of Emerging Concern (CECs): Database Compilation and Application to Urine Samples. Anal. Chem. XXX, XXXX-XXXX (2021)


25
Ross, D. H., et al. High-Throughput Measurement and Machine Learning-Based Prediction of Collision Cross Sections for Drugs and Drug Metabolites. J Am Soc Mass Spectr 33, 1061–1072 (2022).


26
EH Palm, J Engelhardt, S Tshepelevitsh, J Weiss, A Kruve (2024) J Am Soc Mass Spectrom DOI:10.1021/jasms.4c00035


27
Baker, E. S. et al. METLIN-CCS Lipid Database: An authentic standards resource for lipid classification and identification Nat. Metab. 6, 981-982 (2024).


28
HB Muller, G Scholl, J Far, E de Pauw, G Eppe (2023) Anal Chem 95(48): 17586-17594


29
Coming Soon...


ID Name Adduct Structure m/z CCS SMI Type Z Ref CCS Type CCS method
CCSBASE_db641e3eac4a69f7e8574ae368bf0577 C18:1 Cyclic LPA [M-H]- 403.2618706 199.9 CCCCCCCC/C=C\CCCCCCCCOC[C@@H]1COP(=O)(O1)O Organic acids and derivatives -1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_dc8b65755df02f993647307c5519fde1 C18:1 Dihydroceramide (d18:0/18:1(9Z)) [M+Na]+ 588.532586 260.233333333 None None 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_30de58ae69b5110339bc693b9b261e55 C18:1 Dihydroceramide (d18:0/18:1(9Z)) [M+H]+ 566.55064207 262.166666667 None None 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_6c76e6485926eacde6b4d18dc516d545 C18:1 Dihydroceramide (d18:0/18:1(9Z)) [M+HCOO]- 610.5415688 264.3 None None -1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_8a2f949472927cebe228db8c30ff7430 C18:1 Galactosyl(b) Ceramide (d18:1/18:1(9Z)) [M+Na]+ 748.5697578 281.833333333 [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@H]([C@H]1CO)O Lipids and lipid-like molecules 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_346eeb2830d7aaad4a1d1ddf7326b148 C18:1 Galactosyl(b) Ceramide (d18:1/18:1(9Z)) [M+H]+ 726.58781387 284.933333333 [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@H]([C@H]1CO)O Lipids and lipid-like molecules 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_d38e804f595caabcb58f0b29631b6cbf C18:1 Galactosyl(b) Ceramide (d18:1/18:1(9Z)) [M+H-H2O]+ 708.5772432 285.033333333 [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@H]([C@H]1CO)O Lipids and lipid-like molecules 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_080da0f2f0f9de6b65050ac6e6f36d9d C18:1 Galactosyl(b) Ceramide (d18:1/18:1(9Z)) [M+Cl]- 760.549939 283.766666667 [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@H]([C@H]1CO)O Lipids and lipid-like molecules -1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_17dc511a7fbb53d2c854aaf8c6b7e1c0 C18:1 Galactosyl(b) Ceramide (d18:1/18:1(9Z)) [M+HCOO]- 770.5787406 288.6 [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@H]([C@H]1CO)O Lipids and lipid-like molecules -1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
CCSBASE_abce0a0d87b322591595e13487acdc47 C18:1 Glucosyl(b) Ceramide (d18:1/18:1(9Z)) [M+Na]+ 748.5697578 282.4 [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O Lipids and lipid-like molecules 1 27 TIMS calibrated with ESI Low Concentration Tuning Mix (Agilent)
1 2 ... 1865 1866 1867 1868 1869 1870 1871 ... 2315 2316